Fundz

Zetta Genomics secures additional £1.8M in seed funding for genomic data analysis platform

RECENTLY ACQUIREDFeb 08, 2024

Amount Raised

£1.8 Million

Round Type

Seed

Biotechnology

Investors

We Venture Capital

Description

Zetta Genomics secures additional £1.8M in seed funding for genomic data analysis platform. The funding will support the further development of XetaBase.

Quick answer

Zetta Genomics raised £1.8 Million in a Seed round, dated February 8, 2024. Investors: We Venture Capital.

How much did Zetta Genomics raise?
Zetta Genomics raised £1.8 Million in a Seed round on February 8, 2024.
Who invested in Zetta Genomics?
We Venture Capital is named as investors in this round.
What does Zetta Genomics do?
New investment comes from existing VC backers as the company configures for Series A funding.
Who are the decision-makers at Zetta Genomics?
Fundz holds 1 contact at Zetta Genomics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Zetta Genomics that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $665K (Seed) on March 24, 2024.
  • Delphinus Medical Technologies raised $5.3M on March 22, 2024.
  • Sequana Medical raised $12M on March 22, 2024.
  • LungLife AI, Inc. raised $316K (Seed) on March 22, 2024.
  • ONWARD Medical raised $22M (Funding Round) on March 22, 2024.
  • NurExone Biologic raised $43K (Seed) on March 22, 2024.

Who to call at Zetta Genomics, and when

A new round usually means Zetta Genomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Zetta Genomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zetta Genomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zetta Genomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zetta Genomics

About

New investment comes from existing VC backers as the company configures for Series A funding. In just 13 months, the company has: - attracted global leadership talent – including CEO Mark Bailey; - grown headcount from five to 30; - opened new headquarters in Cambridge UK and an office in Valencia, Spain; - expanded genomes under management to over 120,000; - progressed towards CA, CE and ISO 20000-1 certification; - met an ambitious £800,000 revenue target; - built out strategic partnerships with industry leaders including Microsoft, Fujitsu and Syneos. By helping to enable the era of genomic medicine, we believe the Zetta platform has the potential to improve health outcomes for millions of people around the world in the next few years. We are delighted to see the strong progress the company has made and very much look forward to continuing to support them”. To find out more about Zetta Genomics and the XetaBase genomic data management and analytics platform, please contact info@zettagenomics.com. The company invests in need-driven founders inspired by a vision for the future in which data, computing, IoT and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. It was apparent from our early meetings with the founder, Ignacio Medina, that Zetta Genomics was developing not only a high-impact technology, but a paradigm-shifting one. It is a future that depends on transformational genomic data management and analytics – and Zetta Genomics is uniquely positioned Founded in 2017, Zetta Genomics is a fast-scaling genomic data technology company headquartered in Cambridge, UK, with offices in Valencia, Spain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zetta Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Zetta Genomics's next move

See what Strategic adds

Zetta Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.